Want to join the conversation?
$MDCO said it has recruited and dosed the first patient in a proof-of-concept intravascular ultrasound study, MILANO-PILOT, that assesses safety and efficacy of MDCO-216. The study involves about 120 patients with acute coronary syndrome. First interim analysis is expected in 1H16. The study will take place at sites in North America and Europe.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!